Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial. Dillon HT, Saner NJ, Ilsley T, Kliman DS, et al. Circulation 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.

Read + Share

Amedeo Smart

Independent Medical Education

Dillon HT, Saner NJ, Ilsley T, Kliman DS, et al. Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial. Circulation 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
PMID: 39492713